Morgan Stanley Lowers Price Target on Thermo Fisher Scientific to $620 From $670, Keeps Overweight Rating

Morgan Stanley has reduced its price target for Thermo Fisher Scientific (TMO) from $670 to $620, while maintaining an “Overweight” rating on the stock. This adjustment comes amidst other analyst price target revisions for the company.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin